K.W. Fiori et al. / Tetrahedron 65 (2009) 3042–3051
3049
35.1, 31.2, 24.1, 22.4, 13.9 ppm; IR (thin film)
n
3266, 2956, 2932,
4.3.1.11. trans-4-Phenyl-5-(methoxymethyl)tetrahydro-1,2,3-oxathia-
zine-2,2-dioxide (Table 1, entry 8). Purified by chromatography on
silica gel (4:1 hexanes/EtOAc); white solid: TLC Rf¼0.51 (2:1 hex-
2862, 1499, 1456, 1417, 1363, 1190, 1091, 1055, 1014, 912, 876, 795,
753 cmꢁ1; HRMS (ESþ) calcd for C14H21NO3S 283.1242, found
306.1142 (MNaþ).
anes/EtOAc); 1H NMR (CDCl3, 400 MHz)
d 7.45–7.38 (m, 3H), 7.33–
7.30 (m, 2H), 4.81 (t, 1H, J¼11.7 Hz), 4.70 (dd, 1H, J¼11.2, 8.6 Hz),
4.66 (dd, 1H, J¼11.7, 4.7 Hz), 4.41 (br d, 1H, J¼8.6 Hz), 3.17 (s, 3H),
3.13 (dd, 1H, J¼9.8, 3.1 Hz), 3.01 (dd, 1H, J¼9.8, 6.5 Hz), 2.50–2.40
4.3.1.6. 4-Propyl-6-(2-phenylethyl)tetrahydro-1,2,3-oxathiazine-2,2-
dioxide (Table 1, entry 3). Purified by chromatography on silica gel
(gradient elution: 9:1/4:1 hexanes/EtOAc); colorless oil: TLC
(m, 1H) ppm; 13C NMR (CDCl3, 100 MHz)
d
136.7, 129.4, 129.3, 127.1,
Rf¼0.27 (4:1 hexanes/EtOAc); 1H NMR (CDCl3, 400 MHz)
d
7.33–
74.7, 68.9, 61.1, 59.1, 39.8 ppm; IR (thin film) n 3271, 2926, 1457,
7.27 (m, 2H), 7.24–7.18 (m, 3H), 4.82 (sept, 1H, J¼4.3 Hz), 4.22 (br d,
1H, J¼7.6 Hz), 3.68–3.60 (m, 1H), 2.88 (ddd, 1H, J¼14.0, 9.1, 5.1 Hz),
2.73 (ddd, 1H, J¼14.0, 9.1, 7.4 Hz), 2.36–2.26 (m, 1H), 1.94–1.84 (m,
3H), 1.68 (ddd, 1H, J¼14.4, 5.6, 4.0 Hz), 1.58–1.42 (m, 2H), 1.42–1.31
(m, 1H), 0.93 (t, 3H, J¼7.2 Hz) ppm; 13C NMR (CDCl3, 100 MHz)
1426, 1362, 1190, 1123, 1023, 973, 932, 880, 789 cmꢁ1; HRMS (ESþ)
calcd for C11H15NO4S 257.0722, found 280.0624 (MNaþ).
4.3.1.12. 3-Oxa-2-thia-1-azabicyclo[5.1.0]octane-2,2-dioxide (Table
2, entry 1). Purified by chromatography on silica gel (gradient
elution: 2:1/1:1 hexanes/EtOAc); clear oil: TLC Rf¼0.26 (1:1
d
140.5, 128.6, 128.5, 126.2, 81.6, 53.3, 36.3, 35.3, 33.5, 31.1, 19.3,
13.6 ppm; IR (thin film)
n
3273, 2959, 2933, 2871, 1455, 1420, 1375,
hexanes/EtOAc); 1H NMR (CDCl3, 400 MHz)
d 4.28–4.14 (m, 2H),
1184, 913, 869, 811 cmꢁ1; HRMS (ESþ) calcd for C14H21NO3S
283.1242, found 306.1148 (MNaþ).
2.87–2.81 (m, 1H), 2.72 (d, 1H, J¼5.2 Hz), 2.55–2.46 (m, 1H), 2.53 (d,
1H, J¼5.2 Hz), 2.42–2.31 (m, 1H), 1.99–1.82 (m, 2H) ppm; 13C NMR
(CDCl3, 100 MHz)
d 77.2, 71.3, 39.6, 26.6, 26.2 ppm.
4.3.1.7. 4,4-Dimethyl-6-propyltetrahydro-1,2,3-oxathiazine-2,2-dioxi-
de (Table 1, entry 4). Purified by chromatography on silica gel (6:1
CH2Cl2/hexanes); white solid: TLC Rf¼0.26 (10:1 CH2Cl2/EtOAc); 1H
4.3.1.13. 4-Ethenyltetrahydro-1,2,3-oxathiazine-2,2-dioxide (Table 2,
entry 1). Clear oil: TLC Rf¼0.52 (1:1 hexanes/EtOAc); 1H NMR
NMR (CDCl3, 400 MHz)
d
4.82–4.76 (m, 1H), 4.49 (br s, 1H), 1.75–
(CDCl3, 400 MHz)
d
5.83 (ddd, 1H, J¼17.3, 10.7, 4.9 Hz), 5.32 (dd, 1H,
1.64 (m, 1H), 1.62–1.35 (m, 5H), 1.44 (s, 3H), 1.26 (s, 3H), 0.91 (t, 3H,
J¼17.3, 1.8 Hz), 5.30 (dd, 1H, J¼10.7, 1.7 Hz), 4.81–4.74 (m, 1H), 4.60–
4.55 (m, 1H), 4.40–4.32 (m, 1H), 3.97 (br d, 1H, J¼9.0 Hz), 1.90–1.84
J¼7.3 Hz) ppm; 13C NMR (CDCl3, 100 MHz)
d
81.0, 55.8, 41.4, 37.2,
31.8, 25.1, 17.8, 13.6 ppm; IR (thin film)
n
3266, 2963, 2876, 1466,
(m, 2H) ppm; 13C NMR (CDCl3, 100 MHz)
d 134.9, 117.4, 71.6, 56.8,
1422, 1351, 1193, 1157, 1005, 945, 878, 801 cmꢁ1; HRMS (EI) calcd
for C8H17NSO3 207.0929, found 208.1013 (MHþ).
29.2 ppm; IR (thin film) n 3258, 2962, 2924, 2851, 1421, 1357, 1242,
1186, 1136, 1061, 1015, 988, 936, 864, 783 cmꢁ1; HRMS (ESþ) calcd
for C5H9NO3S 163.0303, found 186.0199 (MNaþ).
4.3.1.8. 4-(2-Methylpropyl)-3-oxa-2-thia-1-azaspiro[5.5]undecane-2,
2-dioxide (Table 1, entry 6). Purified by chromatography on silica gel
(9:1 hexanes/EtOAc); white solid: TLC Rf¼0.64 (2:1 hexanes/EtOAc);
4.3.1.14. trans-8-Methyl-3-oxa-2-thia-1-azabicyclo[5.1.0]octane-2,2-
dioxide (Table 2, entry 2). Purified by chromatography on silica gel
(gradient elution: 2:1/1:1 hexanes/EtOAc); clear oil: TLC Rf¼0.26
1H NMR (CDCl3, 400 MHz)
d
4.91 (dddd, 1H, J¼11.7, 9.0, 4.3, 1.9 Hz),
3.73 (s, 1H), 2.51–2.42 (m, 1H), 1.92–1.82 (m, 1H), 1.77–1.57 (m, 5H),
1.52–1.28 (m, 7H), 1.34 (ddd, 1H, J¼14.2, 8.5, 4.3 Hz), 0.95 (t, 3H,
J¼6.6 Hz), 0.93 (t, 3H, J¼6.6 Hz) ppm; 13C NMR (CDCl3, 100 MHz)
(1:1 hexanes/EtOAc); 1H NMR (CDCl3, 400 MHz)
d 4.27–4.12 (m,
2H), 2.99 (dt, 1H, J¼8.0, 4.0 Hz), 2.62–2.56 (m, 1H), 2.51–2.42 (m,
1H), 2.41–2.30 (m, 1H), 1.98–1.81 (m, 2H), 1.37 (d, 3H,
d
78.7, 57.9, 44.2, 41.6, 40.5, 32.9, 25.6, 23.8, 22.8, 21.9, 21.1,
J¼6.3 Hz) ppm; 13C NMR (CDCl3, 100 MHz)
d 77.2, 71.2, 47.1, 26.9,
20.8 ppm; IR (thin film)
n
3254, 2934, 2864, 1447, 1419, 1386, 1347,
26.4, 17.0 ppm.
1278, 1188, 1158, 1104, 1061, 1028, 994, 974, 939, 877, 791 cmꢁ1
;
HRMS (ESþ) calcd for C12H23NO3S 261.1399, found 284.1304
(MNaþ).
4.3.1.15. 4-((1E)-1-Propenyl)tetrahydro-1,2,3-oxathiazine-2,2-dioxide
(Table 2, entry 2). Clear oil: TLC Rf¼0.32 (2:1 hexanes/EtOAc); 1H
NMR (CDCl3, 400 MHz) d 5.83–5.73 (m, 1H), 5.47–5.39 (m, 1H), 4.75
4.3.1.9. 4,4-Dimethyl-6-(cyclohexylmethyl)tetrahydro-1,2,3-oxathia-
zine-2,2-dioxide (Table 1, entry 6). Purified by chromatography on
silica gel (9:1 hexanes/EtOAc); white solid: TLC Rf¼0.57 (2:1 hex-
(td, 1H, J¼11.7, 3.2 Hz), 4.55 (ddd, 1H, J¼11.7, 4.8, 1.9 Hz), 4.32–4.24
(m, 1H), 3.94 (br d, 1H, J¼9.2 Hz), 1.92–1.86 (m, 2H), 1.73 (dt, 3H,
J¼6.6, 1.4 Hz) ppm; 13C NMR (CDCl3, 100 MHz)
d 129.4, 128.0, 71.6,
56.7, 29.7, 17.8 ppm; IR (thin film) n 3260, 2922, 2853, 1421, 1355,
anes/EtOAc); 1H NMR (CDCl3, 400 MHz)
d
4.93 (dddd, 1H, J¼11.2,
9.0, 4.2, 2.3 Hz), 3.89 (s, 1H), 1.85–1.77 (m, 1H), 1.74–1.63 (m, 5H),
1.62–1.51 (m, 3H), 1.51 (s, 3H), 1.37 (ddd, 1H, J¼14.0, 8.4, 4.1 Hz),
1.29 (s, 3H), 1.29–1.09 (m, 3H), 1.11–0.83 (m, 2H) ppm; 13C NMR
1236, 1186, 1130, 1077, 1049, 1010, 968, 936, 889, 864, 780 cmꢁ1
;
HRMS (ESþ) calcd for C6H11NO3S 177.0460, found 200.0355 (MNaþ).
(CDCl3, 100 MHz)
26.1, 25.9, 25.1 ppm; IR (thin film)
1389, 1373, 1351, 1276, 1192, 1162, 1038, 1012, 944, 871, 801,
787 cmꢁ1; HRMS (ESþ) calcd for C12H23NO3S 261.1399, found
284.1292 (MNaþ).
d
79.1, 55.8, 42.8, 41.9, 33.6, 33.0, 32.5, 31.9, 26.3,
3265, 2925, 2852, 1449, 1422,
4.3.1.16. cis-8-Methyl-3-oxa-2-thia-1-azabicyclo[5.1.0]octane-2,2-di-
oxide (Table 2, entry 3). Purified by chromatography on silica gel
(gradient elution: 9:1/4:1 hexanes/EtOAc); clear oil: TLC Rf¼0.43
n
(2:1 hexanes/EtOAc); 1H NMR (CDCl3, 400 MHz)
d 4.43 (dddd, 1H,
J¼11.9, 5.3, 1.8, 1.0 Hz), 4.30 (td, 1H, J¼11.9, 3.6 Hz), 3.11 (quint, 1H,
J¼6.2 Hz), 2.83 (quint, 1H, J¼5.3 Hz), 2.36–2.20 (m, 2H), 2.15–1.99
(m, 2H), 1.64 (d, 3H, J¼6.4 Hz) ppm; 13C NMR (CDCl3, 100 MHz)
4.3.1.10. 4,4-Dimethyl-5-(methoxymethyl)tetrahydro-1,2,3-oxathia-
zine-2,2-dioxide (Table 1, entry 7). Purified by chromatography on
silica gel (gradient elution: 3:1/2:1 hexanes/EtOAc); clear oil: TLC
d
77.2, 71.9, 44.5, 26.0, 22.2, 9.2 ppm; IR (thin film) n 2972, 2932,
1439, 1363, 1290, 1259, 1180, 1114, 1062, 1006, 983, 966, 916, 889,
847, 825, 761 cmꢁ1
Rf¼0.47 (1:1 hexanes/EtOAc); 1H NMR (CDCl3, 400 MHz)
d
4.69 (dd,
.
1H, J¼12.0, 4.0 Hz), 4.60 (dd,1H, J¼12.0, 8.7 Hz), 4.25 (br s, 1H), 3.48
(dd, 1H, J¼9.6, 4.3 Hz), 3.34 (s, 3H), 3.27 (dd, 1H, J¼9.6, 8.4 Hz),
2.03–1.96 (m, 1H), 1.41 (s, 3H), 1.35 (s, 3H) ppm; 13C NMR (CDCl3,
4.3.1.17. 4-((1Z)-1-Propenyl)tetrahydro-1,2,3-oxathiazine-2,2-dioxide
(Table 2, entry 3). Clear oil: TLC Rf¼0.75 (2:1 hexanes/EtOAc); 1H
100 MHz)
film)
d
71.2, 69.6, 59.2, 58.1, 42.6, 29.7, 29.4, 23.0 ppm; IR (thin
NMR (CDCl3, 400 MHz)
d
5.75 (dddd, 1H, J¼14.0, 10.7, 7.0, 1.2 Hz),
n
3270, 2922, 2851, 1465, 1426, 1391, 1357, 1225, 1185, 1162,
5.24 (dddd, 1H, J¼10.7, 8.0, 3.8, 1.8 Hz), 4.79 (ddd, 1H, J¼12.8, 11.7,
2.5 Hz), 4.65–4.56 (m,1H), 4.56 (ddd,1H, J¼11.7, 4.9,1.5 Hz), 3.90 (br
s, 1H), 1.93–1.81 (m, 1H), 1.75 (dt, 3H, J¼7.0, 1.8 Hz), 1.75–1.69 (m,
1112, 990, 928, 895, 794 cmꢁ1; HRMS (ESþ) calcd for C7H15NO4S
209.0722, found 232.0623 (MNaþ).